Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy

Carcinogenesis. 2004 Jul;25(7):1077-81. doi: 10.1093/carcin/bgh186.

Abstract

In the 25 years since its first description the p53 protein has been shown to play a key role in both tumour suppression and aging. New discoveries about the function and control of p53 continue to emerge every month and attempts to exploit the system to develop better therapeutics and diagnostics are beginning to be successful in the clinic.

MeSH terms

  • Adenoviridae*
  • Animals
  • Cyclin-Dependent Kinase Inhibitor p16
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mutation
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / therapy*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Suppressor Protein p14ARF / genetics
  • Tumor Suppressor Protein p14ARF / metabolism
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*
  • Viral Vaccines / genetics

Substances

  • Cdkn2a protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p16
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Tumor Suppressor Protein p14ARF
  • Tumor Suppressor Protein p53
  • Viral Vaccines
  • dl1520
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2